Gyre Therapeutics, Inc.

Ownership Transactions Reported by 24 Insiders

	Insiders	Shares	%	Avg Price	Total $
Buys	1	+8.11M	99.2%	$0.13	+$1.01M
Sells	1	-63.5K	0.8%	$15.64	-$992K
Net	0	+8.05M	98.4%		+$21.6K

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
GNI Group Ltd.	10%+ Owner	$31.1M	+$1.01M	+3.37%	Oct 30, 2023
Songjiang Ma	President, Director	$1.38M			Aug 14, 2024
Ying Luo	Director	$1.33M			Aug 14, 2024
Nassim Usman	Director	$27.3K	-$992K	-97.3%	Jun 28, 2024
Eddie Williams	Director	$16.4K			Jan 7, 2022
Geoffrey M.D. Ling	Director	$14.9K			Jan 7, 2022
Errol B. Desouza	Director	$14K			Oct 1, 2021
Howard Levy	Chief Medical Officer	$11.3K			Aug 9, 2021
Grant E. Blouse	Chief Scientific Officer	$4.43K			Aug 9, 2022
Jeanne Y. Jew	Director				Sep 9, 2021
Andrea Hunt	Director				Aug 31, 2023
E. Seline Miller	SVP Finance; Interim CFO & PAO				Aug 31, 2023
Sharon Tetlow	Director				Jun 9, 2021
Augustine Lawlor	Director				Aug 31, 2023
GNI Hong Kong Ltd	10%+ Owner				Oct 27, 2023
Gordon Carmichael	Director				Aug 14, 2024
Han Ying	Chief Executive Officer, Director				Aug 14, 2024
Ruoyu Chen	Chief Financial Officer				Aug 14, 2024
Renate Parry	Director				Aug 14, 2024
Charles C. Wu	Chief Executive Officer, Director				Nov 20, 2023
Weiguo Ye	Chief Operating Officer				Nov 20, 2023
Rodney Nussbaum	Director				Aug 14, 2024
Thomas Eastling	Director				Aug 14, 2024
David M. Epstein	Director				Aug 14, 2024

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.